Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jul 28, 2021; 27(28): 4687-4696
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4687
Table 1 Baseline characteristics of the study population according to the presence of hepatocellular carcinoma
Variables
All patients (n = 622)
Patients without HCC (n = 462)
Patients with HCC (n = 160)
P value
Demographic variables
Age, years56.5 ± 13.554.1 ± 13.463.5 ± 11.3< 0.001
Male gender344 (55.3)226 (48.9)118 (73.8)< 0.001
Chronic liver disease355 (57.1)198 (42.9)157 (98.1)< 0.001
Etiology of liver disease< 0.001
Hepatitis B virus211 (33.9)114 (24.7)97 (60.6)
Hepatitis C virus26 (4.2)7 (1.5)19 (11.9)
Alcoholic liver disease72 (11.6)39 (8.4)33 (20.6)
Others46 (7.4)38 (8.2)8 (5.0)
Liver cirrhosis208 (33.4)91 (19.7)117 (73.1)< 0.001
Laboratory variables
Total bilirubin, mg/dL1.4 ± 2.71.3 ± 2.71.8 ± 2.70.072
Albumin, g/dL4.2 ± 1.74.3 ± 1.93.8 ± 0.7< 0.001
Prothrombin time, INR1.1 ± 0.21.0 ± 0.21.1 ± 0.2< 0.001
Alanine aminotransferase, IU/L44.8 ± 88.343.8 ± 99.647.8 ± 42.10.624
AFP level, ng/mL3638.6 ± 58824.218.2 ± 63.814092.6 ± 115614.1< 0.001
AFP-L3 fraction, %6.7 ± 16.71.9 ± 3.920.6 ± 28.0< 0.001
AFP-L3 level, ng/mL833.1 ± 8811.31.1 ± 4.73235.3 ± 17185.1< 0.001
PIVKA-II level, mAU/mL1613.4 ± 10561.637.9 ± 257.36162.5 ± 20185.1< 0.001
ALPs score3488.4 ± 33695.411.9 ± 54.413526.8 ± 65558.1< 0.001
Table 2 Binary regression analysis for the presence of hepatocellular carcinoma

Beta coefficient
Standard error
P value
AFP-L3 level0.0380.0170.021
PIVKA-II level0.0020.0010.003